Global Implantable Drug Delivery Systems Market Size, Share, Trends and Forecast 2022-2030

Description

Market Analysis and Insights: Global Implantable Drug Delivery Systems Market
Drug delivery system introduces therapeutic substance in the body as formulation or device to improve its efficiency and safety. There was requirement drug delivery system that could maintain the steady release of therapeutic drugs within the specific site. Implantable drug delivery system becomes new kind of drug delivery system which can directly implant in the human body to optimize therapeutic properties. This system is more steady, effective, safe and reliable than other drug delivery system. For intravenous drug delivery system, drugs actions were short, and frequent injections were required. For topical drug delivery system, absorption drug may be limited due physiochemical characteristic of drugs. Implantable drug delivery system does not have limitation associated with intravenous and topical drug delivery system beside it is controlled drug delivery system.

The global Implantable Drug Delivery Systems market size is projected to reach US$ 666.9 million by 2028, from US$ 468.4 million in 2021, at a CAGR of 5.1% during 2022-2028.

Fully considering the economic change by this health crisis, Biodegradable accounting for % of the Implantable Drug Delivery Systems global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Diabetic Retinopathy segment is altered to an % CAGR throughout this forecast period.

China Implantable Drug Delivery Systems market size is valued at US$ million in 2021, while the North America and Europe Implantable Drug Delivery Systems are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Implantable Drug Delivery Systems landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Implantable Drug Delivery Systems market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Implantable Drug Delivery Systems market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Implantable Drug Delivery Systems market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Implantable Drug Delivery Systems market.

Impact of Covid-19 Outbreak

This section of the report has explored the overall status of the Covid scenario and has offered valuable insights into the changes in supply chain disruption, fluctuations in demand, etc. The analysts have also focused on the key measures that the companies are opting to withstand the harsh scenario.

Segmental Analysis

The report has been segmented into product and application segments. The researchers have documented all the products present today in the Implantable Drug Delivery Systems market. They have also shed light on the new product innovations and launches by the key players. In the segmental analysis, the analysts have provided revenue forecast figures based on type and application for the period 2017-2028. They have also discussed about the growth rate and potential of each segment for the period 2017-2028.

Implantable Drug Delivery Systems Breakdown Data by Type

Biodegradable

Non-Biodegradable

Implantable Drug Delivery Systems Breakdown Data by Application

Diabetic Retinopathy

Cardiovascular Diseases

Colorectal Cancer

Osteoporosis

Ocular Diseases

Brain Tumors

Other

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Competitive Landscape

This segment focuses on the key players operating in the industry. It underlines all the current and future activities by the prominent manufacturers. By understanding various initiatives being taken up by different players, readers will gain the ability to settle on correct business choices. The authors of the report have provided accurate revenue figures of the companies for the period 2017-2022. The clients are sure to gain the upper hand once they get hold of this report. Key players studied in the research report include:

Boston Scientific Corporation

Bayer Healthcare

Medtronic Inc.

Allergan Inc.

Abbott laboratories

Bausch and Lomb Inc.

Genetech Inc.

PSivda Corporation

Medtronic

Varian Medical System

Arrow International

Neurotech Pharmaceuticals

Replenish Inc.

TABLE OF CONTENT

1 Report Business Overview
1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Implantable Drug Delivery Systems Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Biodegradable

1.2.3 Non-Biodegradable

1.3 Market by Application

1.3.1 Global Implantable Drug Delivery Systems Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Diabetic Retinopathy

1.3.3 Cardiovascular Diseases

1.3.4 Colorectal Cancer

1.3.5 Osteoporosis

1.3.6 Ocular Diseases

1.3.7 Brain Tumors

1.3.8 Other

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global Implantable Drug Delivery Systems Market Perspective (2017-2028)

2.2 Implantable Drug Delivery Systems Growth Trends by Region

2.2.1 Implantable Drug Delivery Systems Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Implantable Drug Delivery Systems Historic Market Size by Region (2017-2022)

2.2.3 Implantable Drug Delivery Systems Forecasted Market Size by Region (2023-2028)

2.3 Implantable Drug Delivery Systems Market Dynamics

2.3.1 Implantable Drug Delivery Systems Industry Trends

2.3.2 Implantable Drug Delivery Systems Market Drivers

2.3.3 Implantable Drug Delivery Systems Market Challenges

2.3.4 Implantable Drug Delivery Systems Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Implantable Drug Delivery Systems Players by Revenue

3.1.1 Global Top Implantable Drug Delivery Systems Players by Revenue (2017-2022)

3.1.2 Global Implantable Drug Delivery Systems Revenue Market Share by Players (2017-2022)

3.2 Global Implantable Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Implantable Drug Delivery Systems Revenue

3.4 Global Implantable Drug Delivery Systems Market Concentration Ratio

3.4.1 Global Implantable Drug Delivery Systems Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Implantable Drug Delivery Systems Revenue in 2021

3.5 Implantable Drug Delivery Systems Key Players Head office and Area Served

3.6 Key Players Implantable Drug Delivery Systems Product Solution and Service

3.7 Date of Enter into Implantable Drug Delivery Systems Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Implantable Drug Delivery Systems Breakdown Data by Type

4.1 Global Implantable Drug Delivery Systems Historic Market Size by Type (2017-2022)

4.2 Global Implantable Drug Delivery Systems Forecasted Market Size by Type (2023-2028)

5 Implantable Drug Delivery Systems Breakdown Data by Application

5.1 Global Implantable Drug Delivery Systems Historic Market Size by Application (2017-2022)

5.2 Global Implantable Drug Delivery Systems Forecasted Market Size by Application (2023-2028)

6 North America

6.1 North America Implantable Drug Delivery Systems Market Size (2017-2028)

6.2 North America Implantable Drug Delivery Systems Market Size by Type

6.2.1 North America Implantable Drug Delivery Systems Market Size by Type (2017-2022)

6.2.2 North America Implantable Drug Delivery Systems Market Size by Type (2023-2028)

6.2.3 North America Implantable Drug Delivery Systems Market Share by Type (2017-2028)

6.3 North America Implantable Drug Delivery Systems Market Size by Application

6.3.1 North America Implantable Drug Delivery Systems Market Size by Application (2017-2022)

6.3.2 North America Implantable Drug Delivery Systems Market Size by Application (2023-2028)

6.3.3 North America Implantable Drug Delivery Systems Market Share by Application (2017-2028)

6.4 North America Implantable Drug Delivery Systems Market Size by Country

6.4.1 North America Implantable Drug Delivery Systems Market Size by Country (2017-2022)

6.4.2 North America Implantable Drug Delivery Systems Market Size by Country (2023-2028)

6.4.3 U.S.

6.4.4 Canada

7 Europe

7.1 Europe Implantable Drug Delivery Systems Market Size (2017-2028)

7.2 Europe Implantable Drug Delivery Systems Market Size by Type

7.2.1 Europe Implantable Drug Delivery Systems Market Size by Type (2017-2022)

7.2.2 Europe Implantable Drug Delivery Systems Market Size by Type (2023-2028)

7.2.3 Europe Implantable Drug Delivery Systems Market Share by Type (2017-2028)

7.3 Europe Implantable Drug Delivery Systems Market Size by Application

7.3.1 Europe Implantable Drug Delivery Systems Market Size by Application (2017-2022)

7.3.2 Europe Implantable Drug Delivery Systems Market Size by Application (2023-2028)

7.3.3 Europe Implantable Drug Delivery Systems Market Share by Application (2017-2028)

7.4 Europe Implantable Drug Delivery Systems Market Size by Country

7.4.1 Europe Implantable Drug Delivery Systems Market Size by Country (2017-2022)

7.4.2 Europe Implantable Drug Delivery Systems Market Size by Country (2023-2028)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Implantable Drug Delivery Systems Market Size (2017-2028)

8.2 Asia-Pacific Implantable Drug Delivery Systems Market Size by Type

8.2.1 Asia-Pacific Implantable Drug Delivery Systems Market Size by Type (2017-2022)

8.2.2 Asia-Pacific Implantable Drug Delivery Systems Market Size by Type (2023-2028)

8.2.3 Asia-Pacific Implantable Drug Delivery Systems Market Share by Type (2017-2028)

8.3 Asia-Pacific Implantable Drug Delivery Systems Market Size by Application

8.3.1 Asia-Pacific Implantable Drug Delivery Systems Market Size by Application (2017-2022)

8.3.2 Asia-Pacific Implantable Drug Delivery Systems Market Size by Application (2023-2028)

8.3.3 Asia-Pacific Implantable Drug Delivery Systems Market Share by Application (2017-2028)

8.4 Asia-Pacific Implantable Drug Delivery Systems Market Size by Region

8.4.1 Asia-Pacific Implantable Drug Delivery Systems Market Size by Region (2017-2022)

8.4.2 Asia-Pacific Implantable Drug Delivery Systems Market Size by Region (2023-2028)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9 Latin America

9.1 Latin America Implantable Drug Delivery Systems Market Size (2017-2028)

9.2 Latin America Implantable Drug Delivery Systems Market Size by Type

9.2.1 Latin America Implantable Drug Delivery Systems Market Size by Type (2017-2022)

9.2.2 Latin America Implantable Drug Delivery Systems Market Size by Type (2023-2028)

9.2.3 Latin America Implantable Drug Delivery Systems Market Share by Type (2017-2028)

9.3 Latin America Implantable Drug Delivery Systems Market Size by Application

9.3.1 Latin America Implantable Drug Delivery Systems Market Size by Application (2017-2022)

9.3.2 Latin America Implantable Drug Delivery Systems Market Size by Application (2023-2028)

9.3.3 Latin America Implantable Drug Delivery Systems Market Share by Application (2017-2028)

9.4 Latin America Implantable Drug Delivery Systems Market Size by Country

9.4.1 Latin America Implantable Drug Delivery Systems Market Size by Country (2017-2022)

9.4.2 Latin America Implantable Drug Delivery Systems Market Size by Country (2023-2028)

9.4.3 Mexico

9.4.4 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Implantable Drug Delivery Systems Market Size (2017-2028)

10.2 Middle East & Africa Implantable Drug Delivery Systems Market Size by Type

10.2.1 Middle East & Africa Implantable Drug Delivery Systems Market Size by Type (2017-2022)

10.2.2 Middle East & Africa Implantable Drug Delivery Systems Market Size by Type (2023-2028)

10.2.3 Middle East & Africa Implantable Drug Delivery Systems Market Share by Type (2017-2028)

10.3 Middle East & Africa Implantable Drug Delivery Systems Market Size by Application

10.3.1 Middle East & Africa Implantable Drug Delivery Systems Market Size by Application (2017-2022)

10.3.2 Middle East & Africa Implantable Drug Delivery Systems Market Size by Application (2023-2028)

10.3.3 Middle East & Africa Implantable Drug Delivery Systems Market Share by Application (2017-2028)

10.4 Middle East & Africa Implantable Drug Delivery Systems Market Size by Country

10.4.1 Middle East & Africa Implantable Drug Delivery Systems Market Size by Country (2017-2022)

10.4.2 Middle East & Africa Implantable Drug Delivery Systems Market Size by Country (2023-2028)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11 Key Players Profiles

11.1 Boston Scientific Corporation

11.1.1 Boston Scientific Corporation Company Details

11.1.2 Boston Scientific Corporation Business Overview

11.1.3 Boston Scientific Corporation Implantable Drug Delivery Systems Introduction

11.1.4 Boston Scientific Corporation Revenue in Implantable Drug Delivery Systems Business (2017-2022)

11.1.5 Boston Scientific Corporation Recent Developments

11.2 Bayer Healthcare

11.2.1 Bayer Healthcare Company Details

11.2.2 Bayer Healthcare Business Overview

11.2.3 Bayer Healthcare Implantable Drug Delivery Systems Introduction

11.2.4 Bayer Healthcare Revenue in Implantable Drug Delivery Systems Business (2017-2022)

11.2.5 Bayer Healthcare Recent Developments

11.3 Medtronic Inc.

11.3.1 Medtronic Inc. Company Details

11.3.2 Medtronic Inc. Business Overview

11.3.3 Medtronic Inc. Implantable Drug Delivery Systems Introduction

11.3.4 Medtronic Inc. Revenue in Implantable Drug Delivery Systems Business (2017-2022)

11.3.5 Medtronic Inc. Recent Developments

11.4 Allergan Inc.

11.4.1 Allergan Inc. Company Details

11.4.2 Allergan Inc. Business Overview

11.4.3 Allergan Inc. Implantable Drug Delivery Systems Introduction

11.4.4 Allergan Inc. Revenue in Implantable Drug Delivery Systems Business (2017-2022)

11.4.5 Allergan Inc. Recent Developments

11.5 Abbott laboratories

11.5.1 Abbott laboratories Company Details

11.5.2 Abbott laboratories Business Overview

11.5.3 Abbott laboratories Implantable Drug Delivery Systems Introduction

11.5.4 Abbott laboratories Revenue in Implantable Drug Delivery Systems Business (2017-2022)

11.5.5 Abbott laboratories Recent Developments

11.6 Bausch and Lomb Inc.

11.6.1 Bausch and Lomb Inc. Company Details

11.6.2 Bausch and Lomb Inc. Business Overview

11.6.3 Bausch and Lomb Inc. Implantable Drug Delivery Systems Introduction

11.6.4 Bausch and Lomb Inc. Revenue in Implantable Drug Delivery Systems Business (2017-2022)

11.6.5 Bausch and Lomb Inc. Recent Developments

11.7 Genetech Inc.

11.7.1 Genetech Inc. Company Details

11.7.2 Genetech Inc. Business Overview

11.7.3 Genetech Inc. Implantable Drug Delivery Systems Introduction

11.7.4 Genetech Inc. Revenue in Implantable Drug Delivery Systems Business (2017-2022)

11.7.5 Genetech Inc. Recent Developments

11.8 PSivda Corporation

11.8.1 PSivda Corporation Company Details

11.8.2 PSivda Corporation Business Overview

11.8.3 PSivda Corporation Implantable Drug Delivery Systems Introduction

11.8.4 PSivda Corporation Revenue in Implantable Drug Delivery Systems Business (2017-2022)

11.8.5 PSivda Corporation Recent Developments

11.9 Medtronic

11.9.1 Medtronic Company Details

11.9.2 Medtronic Business Overview

11.9.3 Medtronic Implantable Drug Delivery Systems Introduction

11.9.4 Medtronic Revenue in Implantable Drug Delivery Systems Business (2017-2022)

11.9.5 Medtronic Recent Developments

11.10 Varian Medical System

11.10.1 Varian Medical System Company Details

11.10.2 Varian Medical System Business Overview

11.10.3 Varian Medical System Implantable Drug Delivery Systems Introduction

11.10.4 Varian Medical System Revenue in Implantable Drug Delivery Systems Business (2017-2022)

11.10.5 Varian Medical System Recent Developments

11.11 Arrow International

11.11.1 Arrow International Company Details

11.11.2 Arrow International Business Overview

11.11.3 Arrow International Implantable Drug Delivery Systems Introduction

11.11.4 Arrow International Revenue in Implantable Drug Delivery Systems Business (2017-2022)

11.11.5 Arrow International Recent Developments

11.12 Neurotech Pharmaceuticals

11.12.1 Neurotech Pharmaceuticals Company Details

11.12.2 Neurotech Pharmaceuticals Business Overview

11.12.3 Neurotech Pharmaceuticals Implantable Drug Delivery Systems Introduction

11.12.4 Neurotech Pharmaceuticals Revenue in Implantable Drug Delivery Systems Business (2017-2022)

11.12.5 Neurotech Pharmaceuticals Recent Developments

11.13 Replenish Inc.

11.13.1 Replenish Inc. Company Details

11.13.2 Replenish Inc. Business Overview

11.13.3 Replenish Inc. Implantable Drug Delivery Systems Introduction

11.13.4 Replenish Inc. Revenue in Implantable Drug Delivery Systems Business (2017-2022)

11.13.5 Replenish Inc. Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

Delivery Format : EXCEL/Data Pack

Choose License Type

Checkout Inquiry Sample